ANCA-associated vasculitis (GPA/MPA)
- Induce remission with glucocorticoid + rituximab/cyclophosphamide
- Rituximab is preferred in many relapsing/PR3 cases
- Avacopan can reduce glucocorticoid exposure
- Plasma exchange only for selected severe situations
- Maintain remission with rituximab or other immunosuppressant
- Prophylax infection/bone complications during intensive therapy
Use at a glance
- Induce remission with glucocorticoid + rituximab/cyclophosphamide
Practical pearls
- Rituximab is preferred in many relapsing/PR3 cases
Treatment options
- Avacopan can reduce glucocorticoid exposure
- Prophylax infection/bone complications during intensive therapy
Choosing treatment
- Plasma exchange only for selected severe situations
- Maintain remission with rituximab or other immunosuppressant
Self-check
- What is a key treatment approach for ANCA-associated vasculitis (GPA/MPA)?
Rituximab is preferred in many relapsing/PR3 cases.
Drugs used for this (2)
All clinical uses · Open the interactive console ↗
